Can microdosing psilocybin treat addiction?

Microdosing psilocybin—i.e. the practice of ingesting low, sub-hallucinogenic doses to improve psychological conditions or boost performance—has gained interest in recent years. Many microdosers report beneficial effects, and early research suggests measurable changes in cognitive and emotional functioning.

This raises a question:

Can microdosing psilocybin be used in addiction recovery?

In short, yes: the effects of microdosed psilocybin can be leveraged for recovery from both substance misuse and behavioural addictions, for people with certain profiles (see below).

However, microdosing psilocybin is unlikely to automatically drive addiction recovery. Rather, it acts as an adjunct that enables healing. How? Read more below.

Crucially, if not done intentionally and strategically, adding microdosed psilocybin to an active addiction can do more harm than good. A methodological approach is necessary to ensure its benefits are directed towards the goal of overcoming addiction, rather than fueling self-deception.

How can microdosing psilocybin help with addiction recovery?

Mechanism of action

Microdosed psilocybin, converted by the body into psilocin, acts primarily on certain serotonin receptors in the brain. It positively impacts mood, energy levels, motivation, focus and various executive functions, and can support creativity, mental flexibility and adaptability.

These improvements tend to make the symptoms associated with reducing or discontinuing an addictive substance or behaviour more manageable. They may also positively impact the underlying conditions associated with addiction and facilitate shifts in perspective and habit change.

These effects open an opportunity window to do the deeper healing work to recover from addiction.

Limitations and risks

It is important to highlight that whilst microdosing psilocybin can play a strong supportive role in addiction recovery, it is unlikely to be a stand‑alone cure or circumvent the necessary work to address the root causes of addiction.

More importantly, microdosing for addiction carries real risks if not approached intentionally and strategically. “Adding microdosed psilocybin to an already chaotic addiction landscape without a proper framework may end up merely improving one’s capacity to function while using, instead of propelling addiction recovery,” says Lina B. Russell, an addiction recovery coach specialised in microdosing for addiction.

“This effect is, of course, temporary and creates a host of new problems down the line. It is crucial to seek out proper guidelines and learn methods to effectively apply microdosed psilocybin in addiction recovery, not to waste this important opportunity,” she adds.

This is because addiction recovery requires meaningful improvements in the struggling person’s psychological competencies (such as self-regulation) and in their socio‑environmental context. Thus, microdosing psilocybin for addiction works best as part of a broader recovery plan.

Best practices

“To fully reap these benefits, it is essential to create a microdosing protocol that responds to addiction patterns and to put in place a monitoring framework,” explains Lina B. Russell. “This helps ensure that positive effects of microdosed psilocybin are channelled towards recovery rather than self-deception.”

People struggling with addiction can also benefit from working with an addiction therapist or a recovery coach experienced in this practice, who can provide structure, support, perspective, and accountability.

Is microdosing psilocybin for addiction suitable for everyone?

Who it can help

In short, no. Not everyone is a suitable candidate for using microdosed psilocybin for managing and overcoming addiction. Whether it can support recovery depends on the person’s profile, the severity of their addiction, and their current circumstances.

Microdosing psilocybin for addiction recovery is most suitable for people who are still functioning in day-to-day life and retain some capacity for self-direction. In practical terms, this means they are, at least to some extent:

keeping the show running — work, family, studies, and basic routines are generally maintained;
somehow still in command — despite regular substance use or engagement in addictive behaviour, they are not completely out of control and retain some capacity to make small, steady changes;
out of denial — they recognise there is a problem, even if it is only a quiet voice at the back of their mind.

Who it won’t help or may harm

Medical contraindications: Certain people should not microdose. There are risks associated with certain psychiatric, cognitive and physical medical conditions, alongside risks of interaction with prescription medication and recreational drugs. If needed, discuss your individual case with a qualified clinician.

Denial and self-deception risk: People still in denial about their addiction are unlikely to channel the benefits of microdosed psilocybin towards their recovery and do the necessary healing work. Instead, they may temporarily increase their capacity to use, thus deepening both their addiction and self-deception.

Aspects to consider

When timing is wrong

For some people, microdosing psilocybin for addiction recovery may not be suitable at a given moment — particularly when there are safety, medical, or stability concerns. This may apply, for example, to people who:

require immediate detoxification or medical stabilisation;
cause safety concerns to others or themselves;
are prone to impulsive, reckless, or erratic behaviour, including excessive spending;
are in life circumstances that make preparation, storage, or accurate dosing difficult.

In such situations, addressing these urgent concerns is a priority. Seeking professional support, stabilising in a safe setting, and putting in place basic safeguards come before introducing microdosing.

The time for microdosing psilocybin to support addiction recovery may come, but this method requires a degree of stability and self-control.

Legal constraints

The legality of psilocybin mushrooms or truffles varies by location and must be taken into account. Microdosing psilocybin is not appropriate in settings where possession, cultivation, purchase, or use carries a risk of criminal penalties.

In addition, occupational safety requirements and the possibility of drug testing should be considered before deciding whether this approach is feasible.

Individual differences

Microdosing psilocybin is not a cure, but for some people it can meaningfully support addiction recovery. How helpful it is depends on a combination of factors, including the nature of one’s addiction, the person’s health and circumstances, their response to microdosed psilocybin, how well the microdosing protocol suits the addiction pattern, and whether an accountability framework and a broader recovery plan are both in place.

For this reason, the decision to start microdosing psilocybin for addiction should always be based on an individual assessment, ideally carried out with a medical professional, an addiction therapist, or a recovery coach experienced in this practice.

See sources.

Do you have any questions about this text? Ask them in the comments below. They are answered by Lina B. Russell, an addiction recovery coach specialised in microdosing psilocybin.